Linkage Projects - Grant ID: LP0882953

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP0882953

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Antiviral compounds to inhibit the replicase of hepatitis C virus. Hepatitis C virus is a major public health problem. There are currently 200,000 infected individuals in Australia and 16,000 new infections every year. There is no specific treatment and current therapy treats a small percentage of patients only, which consists of interferon-alpha and ribavirin. This results in side effects and only a 50% cure rate. This study's outcomes are expected to lead to greater access to treatment and improved therapy resulting in higher cure rates and in a dramatic reduction in the cost of treating patients. A novel therapy will provide considerable benefits for the national biotechnology industry.

Funded Activity Details

Start Date: 31-03-2009

End Date: 30-06-2012

Funding Scheme: Linkage Projects

Funding Amount: $76,881.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Other Medical and Health Sciences | Infectious Diseases | Therapies And Therapeutic Technology | Medical Virology |

ANZSRC Socio-Economic Objective (SEO)

Treatments (e.g. chemicals, antibiotics)

Other Keywords

Infectious Diseases | Medical Virology | Other Medical and Health Sciences | Therapies And Therapeutic Technology | Treatments (e.g. chemicals, antibiotics)

Related Links